HIGHLIGHTS
- who: Yuqin Zang from the University of Virginia, United States have published the article: The roles and clinical applications of interleukins in endometrial carcinoma, in the Journal: (JOURNAL)
- what: For the IL-17 levels in serum, Brooks et_al reported no significant difference between EC patients and women without cancer, but this study has an obvious limitation of sample size that it only included 12 EC patients and 10 controls. This study provided a scientific basis for developing the sensitizer to GSDMD-targeted therapy in the clinical management of EC.
- how: These results indicated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.